m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0193)
| Name |
Levetiracetam
|
||||
|---|---|---|---|---|---|
| Synonyms |
102767-28-2; Keppra; (S)-2-(2-Oxopyrrolidin-1-yl)butanamide; Keppra XR; Levetiracetamum; ucb L059; (2S)-2-(2-oxopyrrolidin-1-yl)butanamide; UCB-L 059; UCB-L059; Spritam; (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; (-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; SIB-S1; UNII-44YRR34555; 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-; UCB-22059; Levetiracetamum [INN-Latin]; Levetiractam; CHEBI:6437; ucb L060; Levetiracetam In Sodium Chloride; 44YRR34555; Levroxa; 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-,; Leviteracetam; Torleva; Levetiracetam [INN]; Etiracetam levo-isomer; Keppra (TN); L-059; Etiracetam, S-isomer; Keppra, Keppra XR),Levetiracetam; Levetriacetam
Click to Show/Hide
|
||||
| Structure |
 |
||||
|
3D MOL
|
|||||
| Formula |
C8H14N2O2
|
||||
| InChI |
1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
|
||||
| InChIKey |
HPHUVLMMVZITSG-LURJTMIESA-N
|
||||
| PubChem CID | |||||
| TTD Drug ID | |||||
| DrugBank ID | |||||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Drug
| In total 1 item(s) under this drug | ||
| Crosstalk ID: M6ACROT05165 | ||
| m6A Regulator | Zinc finger CCCH domain-containing protein 13 (ZC3H13) | |
| m6A Target | Dual specificity protein phosphatase 9 (DUSP9) | |
| Epigenetic Regulator | hsa-miR-200c-3p | |
| Regulated Target | Zinc finger CCCH domain-containing protein 13 (ZC3H13) | |
| Crosstalk relationship | ncRNA → m6A | |
| Disease | Brain cancer | |